Although loss of heterozygosity of TRAIL-R2 has been observed in approximately half of colorectal carcinomas, mutations of the two TRAIL receptor genes are rare (Arai et al, 1998). This evidence concerns the gene TNFRSF10B and colorectal carcinoma.